A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration

NCT00950638 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
47
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ophthotech Corporation